When is ERA or Matricelab indicated?

The ERA Test (Endometrial Receptivity Analysis) is a molecular diagnostic test that evaluates the receptivity status of the endometrium. Its purpose is to identify the optimal moment in the menstrual cycle for embryo transfer.

It is recommended in the following cases:

• Patients with previous implantation failures in IVF treatments with good-quality embryos.
• Patients who have suffered recurrent miscarriages without an apparent cause.

On the other hand, the MatriceLab Test analyzes immunological factors and possible imbalances affecting embryo implantation. It is recommended in the following cases:

• Patients with suspected immunological alterations in the endometrium, such as chronic inflammation.
• Implantation failures despite the ERA test indicating adequate endometrial receptivity.

What Are the Advantages of Performing These Tests before an IVF Treatment?

1. They allow for a personalized treatment plan based on the patient's endometrial characteristics.
2. To identify the optimal moment for embryo transfer (ERA test) or detect and correct immunological imbalances (MatriceLab test) can improve implantation rates.
3. They help identify endometrial problems that could affect pregnancy success.

The decision to perform these tests should be assessed individually by assisted reproduction specialists.